MXPA05006167A - Composiciones de inhibidores de la proteina de transferencia de colesteril ester e inhibidores de la hmg-coa reductasa. - Google Patents
Composiciones de inhibidores de la proteina de transferencia de colesteril ester e inhibidores de la hmg-coa reductasa.Info
- Publication number
- MXPA05006167A MXPA05006167A MXPA05006167A MXPA05006167A MXPA05006167A MX PA05006167 A MXPA05006167 A MX PA05006167A MX PA05006167 A MXPA05006167 A MX PA05006167A MX PA05006167 A MXPA05006167 A MX PA05006167A MX PA05006167 A MXPA05006167 A MX PA05006167A
- Authority
- MX
- Mexico
- Prior art keywords
- phenyl
- amino
- propanol
- trifluoro
- methyl
- Prior art date
Links
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 title claims abstract description 153
- 239000000203 mixture Substances 0.000 title claims abstract description 115
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title claims abstract description 16
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title claims abstract description 16
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title description 5
- 239000002156 adsorbate Substances 0.000 claims abstract description 126
- 239000000758 substrate Substances 0.000 claims abstract description 122
- 229940125881 cholesteryl ester transfer protein inhibitor Drugs 0.000 claims abstract description 98
- 239000007787 solid Substances 0.000 claims abstract description 96
- 239000003112 inhibitor Substances 0.000 claims abstract description 43
- 108010061846 Cholesterol Ester Transfer Proteins Proteins 0.000 claims abstract description 37
- 102000012336 Cholesterol Ester Transfer Proteins Human genes 0.000 claims abstract description 37
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 490
- -1 isopropyl ester Chemical class 0.000 claims description 369
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 281
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 201
- 229920000642 polymer Polymers 0.000 claims description 131
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 115
- 238000000034 method Methods 0.000 claims description 65
- 150000001875 compounds Chemical class 0.000 claims description 50
- 238000004090 dissolution Methods 0.000 claims description 34
- 239000002609 medium Substances 0.000 claims description 28
- 230000002708 enhancing effect Effects 0.000 claims description 25
- 238000001727 in vivo Methods 0.000 claims description 14
- 238000000338 in vitro Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 239000002552 dosage form Substances 0.000 claims description 11
- 210000004369 blood Anatomy 0.000 claims description 10
- 239000008280 blood Substances 0.000 claims description 10
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 8
- 239000012736 aqueous medium Substances 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- CMSGWTNRGKRWGS-NQIIRXRSSA-N torcetrapib Chemical compound COC(=O)N([C@H]1C[C@@H](CC)N(C2=CC=C(C=C21)C(F)(F)F)C(=O)OCC)CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 CMSGWTNRGKRWGS-NQIIRXRSSA-N 0.000 claims description 7
- 229950004514 torcetrapib Drugs 0.000 claims description 7
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims description 6
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 claims description 6
- 229960005370 atorvastatin Drugs 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 5
- 230000006872 improvement Effects 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 238000002648 combination therapy Methods 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- FJLGEFLZQAZZCD-JUFISIKESA-N (3S,5R)-fluvastatin Chemical compound C12=CC=CC=C2N(C(C)C)C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 FJLGEFLZQAZZCD-JUFISIKESA-N 0.000 claims 2
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 claims 2
- AJLFOPYRIVGYMJ-UHFFFAOYSA-N SJ000287055 Natural products C12C(OC(=O)C(C)CC)CCC=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 AJLFOPYRIVGYMJ-UHFFFAOYSA-N 0.000 claims 2
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 claims 2
- BOZILQFLQYBIIY-UHFFFAOYSA-N mevastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CCC=C21 BOZILQFLQYBIIY-UHFFFAOYSA-N 0.000 claims 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 claims 2
- VDSBXXDKCUBMQC-HNGSOEQISA-N (4r,6s)-6-[(e)-2-[2-(4-fluoro-3-methylphenyl)-4,4,6,6-tetramethylcyclohexen-1-yl]ethenyl]-4-hydroxyoxan-2-one Chemical compound C1=C(F)C(C)=CC(C=2CC(C)(C)CC(C)(C)C=2\C=C\[C@H]2OC(=O)C[C@H](O)C2)=C1 VDSBXXDKCUBMQC-HNGSOEQISA-N 0.000 claims 1
- VGMFHMLQOYWYHN-UHFFFAOYSA-N Compactin Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)c4C(=O)C(=COc4c3)c5ccc(O)c(O)c5)C(O)C(O)C1O VGMFHMLQOYWYHN-UHFFFAOYSA-N 0.000 claims 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims 1
- TUZYXOIXSAXUGO-UHFFFAOYSA-N Pravastatin Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(O)C=C21 TUZYXOIXSAXUGO-UHFFFAOYSA-N 0.000 claims 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 claims 1
- VXDSGTRNDFHIJB-QQPOVDNESA-N [(1s,4ar)-8-[2-[(2r,4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1CCC[C@@H](C21)OC(=O)[C@@H](C)CC)=CC(C)C2CC[C@@H]1C[C@@H](O)CC(=O)O1 VXDSGTRNDFHIJB-QQPOVDNESA-N 0.000 claims 1
- 229960005110 cerivastatin Drugs 0.000 claims 1
- SEERZIQQUAZTOL-ANMDKAQQSA-N cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 claims 1
- GPUADMRJQVPIAS-QCVDVZFFSA-M cerivastatin sodium Chemical compound [Na+].COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 GPUADMRJQVPIAS-QCVDVZFFSA-M 0.000 claims 1
- 229950003040 dalvastatin Drugs 0.000 claims 1
- VXDSGTRNDFHIJB-UHFFFAOYSA-N dihydrocompactin Natural products C12C(OC(=O)C(C)CC)CCCC2C=CC(C)C1CCC1CC(O)CC(=O)O1 VXDSGTRNDFHIJB-UHFFFAOYSA-N 0.000 claims 1
- 229960003765 fluvastatin Drugs 0.000 claims 1
- 150000002596 lactones Chemical group 0.000 claims 1
- 229960004844 lovastatin Drugs 0.000 claims 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims 1
- 229950009116 mevastatin Drugs 0.000 claims 1
- 229960002965 pravastatin Drugs 0.000 claims 1
- TUZYXOIXSAXUGO-PZAWKZKUSA-N pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims 1
- 229960000672 rosuvastatin Drugs 0.000 claims 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 claims 1
- 229960002855 simvastatin Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 description 211
- 229940079593 drug Drugs 0.000 description 211
- 125000000217 alkyl group Chemical group 0.000 description 188
- 125000004432 carbon atom Chemical group C* 0.000 description 182
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 171
- 125000002023 trifluoromethyl group Chemical class FC(F)(F)* 0.000 description 154
- 229910052717 sulfur Inorganic materials 0.000 description 131
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 127
- 125000003545 alkoxy group Chemical group 0.000 description 119
- 229910052757 nitrogen Inorganic materials 0.000 description 114
- 125000004043 oxo group Chemical group O=* 0.000 description 110
- 229920006395 saturated elastomer Polymers 0.000 description 110
- 229910052799 carbon Inorganic materials 0.000 description 106
- 125000003118 aryl group Chemical group 0.000 description 95
- 229910052760 oxygen Inorganic materials 0.000 description 93
- 229910052739 hydrogen Inorganic materials 0.000 description 90
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 88
- 239000001257 hydrogen Substances 0.000 description 88
- 239000011593 sulfur Substances 0.000 description 88
- 125000005843 halogen group Chemical group 0.000 description 87
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 86
- 125000001424 substituent group Chemical group 0.000 description 82
- 229960004592 isopropanol Drugs 0.000 description 79
- 125000000623 heterocyclic group Chemical group 0.000 description 75
- 239000001301 oxygen Substances 0.000 description 74
- 229910052736 halogen Inorganic materials 0.000 description 72
- 125000005842 heteroatom Chemical group 0.000 description 70
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 69
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 66
- 150000002431 hydrogen Chemical class 0.000 description 62
- 239000002904 solvent Substances 0.000 description 62
- 125000003342 alkenyl group Chemical group 0.000 description 61
- 125000004093 cyano group Chemical group *C#N 0.000 description 60
- 125000000753 cycloalkyl group Chemical group 0.000 description 59
- 150000002367 halogens Chemical class 0.000 description 57
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 56
- 125000004414 alkyl thio group Chemical group 0.000 description 56
- GILIYJDBJZWGBG-UHFFFAOYSA-N 1,1,1-trifluoropropan-2-ol Chemical compound CC(O)C(F)(F)F GILIYJDBJZWGBG-UHFFFAOYSA-N 0.000 description 55
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 54
- 125000001072 heteroaryl group Chemical group 0.000 description 51
- 239000000243 solution Substances 0.000 description 49
- 125000006850 spacer group Chemical group 0.000 description 49
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 46
- 125000006343 heptafluoro propyl group Chemical group 0.000 description 45
- 125000000876 trifluoromethoxy group Chemical class FC(F)(F)O* 0.000 description 44
- 125000002252 acyl group Chemical class 0.000 description 42
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 41
- 125000000304 alkynyl group Chemical group 0.000 description 40
- 150000003254 radicals Chemical class 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 125000004429 atom Chemical group 0.000 description 28
- 125000000392 cycloalkenyl group Chemical group 0.000 description 28
- 125000001188 haloalkyl group Chemical group 0.000 description 28
- 125000001153 fluoro group Chemical group F* 0.000 description 26
- 230000008569 process Effects 0.000 description 25
- 239000002253 acid Substances 0.000 description 24
- 125000002947 alkylene group Chemical group 0.000 description 24
- 239000001294 propane Substances 0.000 description 24
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 23
- 125000004494 ethyl ester group Chemical group 0.000 description 23
- 125000000262 haloalkenyl group Chemical group 0.000 description 23
- 230000002209 hydrophobic effect Effects 0.000 description 23
- 239000010410 layer Substances 0.000 description 23
- 239000002245 particle Substances 0.000 description 23
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 description 21
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 21
- 238000012360 testing method Methods 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 125000003710 aryl alkyl group Chemical group 0.000 description 20
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 19
- 150000002148 esters Chemical class 0.000 description 19
- 239000000463 material Substances 0.000 description 19
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 19
- 238000001694 spray drying Methods 0.000 description 19
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 18
- 230000008018 melting Effects 0.000 description 17
- 238000002844 melting Methods 0.000 description 17
- 125000004104 aryloxy group Chemical group 0.000 description 16
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 16
- 125000002619 bicyclic group Chemical group 0.000 description 15
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 14
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 14
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 14
- 125000004438 haloalkoxy group Chemical group 0.000 description 14
- 125000006350 alkyl thio alkyl group Chemical group 0.000 description 13
- 125000005164 aryl thioalkyl group Chemical group 0.000 description 13
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 13
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 13
- 230000007423 decrease Effects 0.000 description 13
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 description 13
- 230000003993 interaction Effects 0.000 description 13
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 12
- 125000005110 aryl thio group Chemical group 0.000 description 12
- 229920002301 cellulose acetate Polymers 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 125000005452 alkenyloxyalkyl group Chemical group 0.000 description 11
- 125000005160 aryl oxy alkyl group Chemical group 0.000 description 11
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 11
- 125000005553 heteroaryloxy group Chemical group 0.000 description 11
- 125000005844 heterocyclyloxy group Chemical group 0.000 description 11
- 125000001145 hydrido group Chemical group *[H] 0.000 description 11
- 239000002953 phosphate buffered saline Substances 0.000 description 11
- QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 description 10
- 125000003282 alkyl amino group Chemical group 0.000 description 10
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 10
- 229920006037 cross link polymer Polymers 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
- 125000004434 sulfur atom Chemical group 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 125000004688 alkyl sulfonyl alkyl group Chemical group 0.000 description 9
- 125000003435 aroyl group Chemical group 0.000 description 9
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 9
- 235000010980 cellulose Nutrition 0.000 description 9
- 229920002678 cellulose Polymers 0.000 description 9
- 239000001913 cellulose Substances 0.000 description 9
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 9
- 125000005368 heteroarylthio group Chemical group 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 8
- 125000004687 alkyl sulfinyl alkyl group Chemical group 0.000 description 8
- 125000004644 alkyl sulfinyl group Chemical group 0.000 description 8
- 125000005140 aralkylsulfonyl group Chemical group 0.000 description 8
- 125000005135 aryl sulfinyl group Chemical group 0.000 description 8
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 8
- 125000002837 carbocyclic group Chemical group 0.000 description 8
- 150000003857 carboxamides Chemical class 0.000 description 8
- 125000004181 carboxyalkyl group Chemical group 0.000 description 8
- 125000005356 cycloalkylalkenyl group Chemical group 0.000 description 8
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 125000000232 haloalkynyl group Chemical group 0.000 description 8
- 125000006769 halocycloalkoxy group Chemical group 0.000 description 8
- 125000005347 halocycloalkyl group Chemical group 0.000 description 8
- 125000005150 heteroarylsulfinyl group Chemical group 0.000 description 8
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 8
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 8
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 8
- 239000007921 spray Substances 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- SHNMAZJVVFUXAQ-UHFFFAOYSA-N 2h-quinoline-1-carboxylic acid Chemical compound C1=CC=C2N(C(=O)O)CC=CC2=C1 SHNMAZJVVFUXAQ-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 125000000000 cycloalkoxy group Chemical group 0.000 description 7
- 125000005149 cycloalkylsulfinyl group Chemical group 0.000 description 7
- NIRMDYUESATWJX-UHFFFAOYSA-N cycloheptene-1-carboxamide Chemical compound NC(=O)C1=CCCCCC1 NIRMDYUESATWJX-UHFFFAOYSA-N 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 7
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 7
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 7
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 6
- 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 125000004447 heteroarylalkenyl group Chemical group 0.000 description 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 6
- 239000002356 single layer Substances 0.000 description 6
- 102000015779 HDL Lipoproteins Human genes 0.000 description 5
- 108010010234 HDL Lipoproteins Proteins 0.000 description 5
- 125000004423 acyloxy group Chemical group 0.000 description 5
- 125000004450 alkenylene group Chemical group 0.000 description 5
- 125000005108 alkenylthio group Chemical group 0.000 description 5
- 125000005109 alkynylthio group Chemical group 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 125000000062 cyclohexylmethoxy group Chemical group [H]C([H])(O*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 5
- 125000004663 dialkyl amino group Chemical group 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 description 5
- 125000003106 haloaryl group Chemical group 0.000 description 5
- 125000005216 haloheteroaryl group Chemical group 0.000 description 5
- 125000004449 heterocyclylalkenyl group Chemical group 0.000 description 5
- 125000004415 heterocyclylalkyl group Chemical group 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 5
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 5
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 5
- 125000003396 thiol group Chemical class [H]S* 0.000 description 5
- UGRMITBWUVWUEB-UHFFFAOYSA-N 1-$l^{1}-oxidanyl-3-methylbenzene Chemical group CC1=CC=CC([O])=C1 UGRMITBWUVWUEB-UHFFFAOYSA-N 0.000 description 4
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 4
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- IYKJEILNJZQJPU-UHFFFAOYSA-N acetic acid;butanedioic acid Chemical compound CC(O)=O.OC(=O)CCC(O)=O IYKJEILNJZQJPU-UHFFFAOYSA-N 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 125000005055 alkyl alkoxy group Chemical group 0.000 description 4
- 125000001769 aryl amino group Chemical group 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229910052731 fluorine Inorganic materials 0.000 description 4
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 description 4
- 125000005241 heteroarylamino group Chemical group 0.000 description 4
- 229920000639 hydroxypropylmethylcellulose acetate succinate Polymers 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000006911 nucleation Effects 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 125000005498 phthalate group Chemical group 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 4
- 150000003536 tetrazoles Chemical group 0.000 description 4
- 125000001544 thienyl group Chemical class 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 4
- 125000005591 trimellitate group Chemical group 0.000 description 4
- LVHVPFOLBJZHDN-UHFFFAOYSA-N (2-methyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamic acid Chemical class C1=CC=C2NC(C)CC(NC(O)=O)C2=C1 LVHVPFOLBJZHDN-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- IIKZNSBHUKXXBH-UHFFFAOYSA-N 2-amino-1,1,1-trifluoropropan-2-ol Chemical compound CC(N)(O)C(F)(F)F IIKZNSBHUKXXBH-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 150000001204 N-oxides Chemical class 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 3
- 125000005354 acylalkyl group Chemical group 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 125000003302 alkenyloxy group Chemical group 0.000 description 3
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 3
- 125000005422 alkyl sulfonamido group Chemical group 0.000 description 3
- 125000005530 alkylenedioxy group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000005018 aryl alkenyl group Chemical group 0.000 description 3
- 125000001691 aryl alkyl amino group Chemical group 0.000 description 3
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 3
- 125000005421 aryl sulfonamido group Chemical group 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical group 0.000 description 3
- 125000005518 carboxamido group Chemical group 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 125000004465 cycloalkenyloxy group Chemical group 0.000 description 3
- 125000004858 cycloalkoxyalkyl group Chemical group 0.000 description 3
- 125000006310 cycloalkyl amino group Chemical group 0.000 description 3
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 description 3
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000007922 dissolution test Methods 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 125000004995 haloalkylthio group Chemical group 0.000 description 3
- 125000004468 heterocyclylthio group Chemical group 0.000 description 3
- 150000004678 hydrides Chemical class 0.000 description 3
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 3
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 3
- 238000000099 in vitro assay Methods 0.000 description 3
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 3
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 3
- 229920001983 poloxamer Polymers 0.000 description 3
- 238000000634 powder X-ray diffraction Methods 0.000 description 3
- 150000003222 pyridines Chemical class 0.000 description 3
- 150000003839 salts Chemical group 0.000 description 3
- 125000005353 silylalkyl group Chemical group 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 125000003003 spiro group Chemical group 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 150000003871 sulfonates Chemical class 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 150000003566 thiocarboxylic acids Chemical class 0.000 description 3
- 125000004665 trialkylsilyl group Chemical group 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- WPUWNCWLDZMYSC-UHFFFAOYSA-N 1-fluoropropan-2-ol Chemical compound CC(O)CF WPUWNCWLDZMYSC-UHFFFAOYSA-N 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- XDZMPRGFOOFSBL-UHFFFAOYSA-N 2-ethoxybenzoic acid Chemical compound CCOC1=CC=CC=C1C(O)=O XDZMPRGFOOFSBL-UHFFFAOYSA-N 0.000 description 2
- CGMMPMYKMDITEA-UHFFFAOYSA-N 2-ethylbenzoic acid Chemical compound CCC1=CC=CC=C1C(O)=O CGMMPMYKMDITEA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229910014585 C2-Ce Inorganic materials 0.000 description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 238000008214 LDL Cholesterol Methods 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 239000006057 Non-nutritive feed additive Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 125000004103 aminoalkyl group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- VYGAQHDGEYQIJU-UHFFFAOYSA-N butanedioic acid;phthalic acid Chemical compound OC(=O)CCC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O VYGAQHDGEYQIJU-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 2
- 229920006218 cellulose propionate Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229910052681 coesite Inorganic materials 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229910052906 cristobalite Inorganic materials 0.000 description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N dimethylmethane Natural products CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 230000002183 duodenal effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000001033 ether group Chemical group 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 238000005462 in vivo assay Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052809 inorganic oxide Inorganic materials 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- IQSHMXAZFHORGY-UHFFFAOYSA-N methyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound COC(=O)C=C.CC(=C)C(O)=O IQSHMXAZFHORGY-UHFFFAOYSA-N 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 125000005254 oxyacyl group Chemical group 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- WSDQIHATCCOMLH-UHFFFAOYSA-N phenyl n-(3,5-dichlorophenyl)carbamate Chemical compound ClC1=CC(Cl)=CC(NC(=O)OC=2C=CC=CC=2)=C1 WSDQIHATCCOMLH-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical class OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- 230000036470 plasma concentration Effects 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000193 polymethacrylate Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- KOODSCBKXPPKHE-UHFFFAOYSA-N propanethioic s-acid Chemical compound CCC(S)=O KOODSCBKXPPKHE-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- 238000007712 rapid solidification Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 229910052682 stishovite Inorganic materials 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 125000005389 trialkylsiloxy group Chemical group 0.000 description 2
- 229910052905 tridymite Inorganic materials 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- 229920006163 vinyl copolymer Polymers 0.000 description 2
- 229920003176 water-insoluble polymer Polymers 0.000 description 2
- MLMAJGJPMOWEJB-UHFFFAOYSA-N (2-cyclopentyl-5-hydroxy-7,7-dimethyl-4-thiophen-3-yl-6,8-dihydro-5h-quinolin-3-yl)-[4-(trifluoromethyl)phenyl]methanone Chemical compound C1C(C)(C)CC(O)C(C(=C2C(=O)C=3C=CC(=CC=3)C(F)(F)F)C3=CSC=C3)=C1N=C2C1CCCC1 MLMAJGJPMOWEJB-UHFFFAOYSA-N 0.000 description 1
- UBFZNTUQUDYRDQ-OAQYLSRUSA-N (2r)-1,1,1-trifluoro-3-[n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-3-[3-(1,1,2,2,2-pentafluoroethyl)phenoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OC=2C=C(C=CC=2)C(F)(F)C(F)(F)F)=CC=1N(C[C@@H](O)C(F)(F)F)CC1=CC=C(C(F)(F)F)C=C1F UBFZNTUQUDYRDQ-OAQYLSRUSA-N 0.000 description 1
- KNXKMBGTUFRPFG-JOCHJYFZSA-N (2r)-1,1,1-trifluoro-3-[n-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]-3-(4-methylphenoxy)anilino]propan-2-ol Chemical compound C1=CC(C)=CC=C1OC1=CC=CC(N(C[C@@H](O)C(F)(F)F)CC=2C(=CC=C(C=2)C(F)(F)F)F)=C1 KNXKMBGTUFRPFG-JOCHJYFZSA-N 0.000 description 1
- CIESSKMUEKLXIP-HXUWFJFHSA-N (2r)-3-[3-(2,3-dichlorophenoxy)-n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C(=C(Cl)C=CC=2)Cl)=CC=1N(C[C@@H](O)C(F)(F)F)CC1=CC=C(C(F)(F)F)C=C1F CIESSKMUEKLXIP-HXUWFJFHSA-N 0.000 description 1
- MZAQGHWLVXTLFD-HXUWFJFHSA-N (2r)-3-[3-(2,3-dichlorophenoxy)-n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C(=C(Cl)C=CC=2)Cl)=CC=1N(C[C@@H](O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)C(F)(F)F)=C1 MZAQGHWLVXTLFD-HXUWFJFHSA-N 0.000 description 1
- JOIWZSPTKKMNKX-HSZRJFAPSA-N (2r)-3-[3-(3,5-dimethylphenoxy)-n-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound CC1=CC(C)=CC(OC=2C=C(C=CC=2)N(C[C@@H](O)C(F)(F)F)CC=2C(=CC=C(C=2)C(F)(F)F)F)=C1 JOIWZSPTKKMNKX-HSZRJFAPSA-N 0.000 description 1
- CBDYIAFHDCVXLZ-HSZRJFAPSA-N (2r)-3-[3-(3-ethylphenoxy)-n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound CCC1=CC=CC(OC=2C=C(C=CC=2)N(C[C@@H](O)C(F)(F)F)CC=2C=C(C=CC=2)C(F)(F)C(F)(F)F)=C1 CBDYIAFHDCVXLZ-HSZRJFAPSA-N 0.000 description 1
- UXGNQFGMQDSUJY-XMMPIXPASA-N (2r)-3-[3-[(3,5-dimethylphenyl)methoxy]-n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound CC1=CC(C)=CC(COC=2C=C(C=CC=2)N(C[C@@H](O)C(F)(F)F)CC=2C=C(C=CC=2)C(F)(F)C(F)(F)C(F)(F)F)=C1 UXGNQFGMQDSUJY-XMMPIXPASA-N 0.000 description 1
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 description 1
- 125000000081 (C5-C8) cycloalkenyl group Chemical group 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- OCGWWLDZAFOHGD-UHFFFAOYSA-N 1,1,1-trifluoro-2-methylpropan-2-ol Chemical compound CC(C)(O)C(F)(F)F OCGWWLDZAFOHGD-UHFFFAOYSA-N 0.000 description 1
- XSHGEXOSXRGAIF-UHFFFAOYSA-N 1,1,1-trifluoro-3-[3-(4-fluorophenoxy)-n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]anilino]propan-2-ol Chemical compound C=1C=CC(OC=2C=CC(F)=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)F)=C1 XSHGEXOSXRGAIF-UHFFFAOYSA-N 0.000 description 1
- ZHUQKYBEVUVRAV-UHFFFAOYSA-N 1,1,1-trifluoro-3-[3-(4-fluorophenoxy)-n-[[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]anilino]propan-2-ol Chemical compound C=1C=CC(OC=2C=CC(F)=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(OC(F)(F)C(F)F)=C1 ZHUQKYBEVUVRAV-UHFFFAOYSA-N 0.000 description 1
- HTWHUNGPMGRCDS-UHFFFAOYSA-N 1,1,1-trifluoro-3-[3-(4-methylphenoxy)-n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]anilino]propan-2-ol Chemical compound C1=CC(C)=CC=C1OC1=CC=CC(N(CC(O)C(F)(F)F)CC=2C=C(C=CC=2)C(F)(F)C(F)(F)F)=C1 HTWHUNGPMGRCDS-UHFFFAOYSA-N 0.000 description 1
- JQTUEDYQKJJZSF-UHFFFAOYSA-N 1,1,1-trifluoro-3-[3-[3-(1,1,2,2,2-pentafluoroethyl)phenoxy]-n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]anilino]propan-2-ol Chemical compound C=1C=CC(OC=2C=C(C=CC=2)C(F)(F)C(F)(F)F)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)F)=C1 JQTUEDYQKJJZSF-UHFFFAOYSA-N 0.000 description 1
- GHEOOXKCCXUKPJ-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-3-(3-methylphenoxy)anilino]propan-2-ol Chemical compound CC1=CC=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC=2C(=CC(=CC=2)C(F)(F)F)F)=C1 GHEOOXKCCXUKPJ-UHFFFAOYSA-N 0.000 description 1
- YXAHUOYKALTYIQ-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]-3-[[3-(trifluoromethylsulfanyl)phenyl]methoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OCC=2C=C(SC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=C(C(F)(F)F)C=C1F YXAHUOYKALTYIQ-UHFFFAOYSA-N 0.000 description 1
- HCTABIYZUVSVJW-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]-3-(3-propan-2-ylphenoxy)anilino]propan-2-ol Chemical compound CC(C)C1=CC=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC=2C(=CC=C(C=2)C(F)(F)F)F)=C1 HCTABIYZUVSVJW-UHFFFAOYSA-N 0.000 description 1
- RJJFLGJPBPKSNZ-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[2-fluoro-5-(trifluoromethyl)phenyl]methyl]-3-phenoxyanilino]propan-2-ol Chemical compound C=1C=CC(OC=2C=CC=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC(C(F)(F)F)=CC=C1F RJJFLGJPBPKSNZ-UHFFFAOYSA-N 0.000 description 1
- OWDYTXAMAKPKMS-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]-3-(3-propan-2-ylphenoxy)anilino]propan-2-ol Chemical compound CC(C)C1=CC=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC=2C=C(C=CC=2)C(F)(F)C(F)(F)F)=C1 OWDYTXAMAKPKMS-UHFFFAOYSA-N 0.000 description 1
- JXIJYGKAJOIFQA-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]-3-[[3-(trifluoromethoxy)phenyl]methoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OCC=2C=C(OC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)F)=C1 JXIJYGKAJOIFQA-UHFFFAOYSA-N 0.000 description 1
- JWBURSGRFHLUQI-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]-3-(3-methylphenoxy)anilino]propan-2-ol Chemical compound CC1=CC=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC=2C=C(C=CC=2)C(F)(F)C(F)(F)C(F)(F)F)=C1 JWBURSGRFHLUQI-UHFFFAOYSA-N 0.000 description 1
- MOYVYFJUYHYWPE-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]-3-(3-propan-2-ylphenoxy)anilino]propan-2-ol Chemical compound CC(C)C1=CC=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC=2C=C(C=CC=2)C(F)(F)C(F)(F)C(F)(F)F)=C1 MOYVYFJUYHYWPE-UHFFFAOYSA-N 0.000 description 1
- FKMDBTLFHAWMTC-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]-3-[3-(trifluoromethoxy)phenoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OC=2C=C(OC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)C(F)(F)F)=C1 FKMDBTLFHAWMTC-UHFFFAOYSA-N 0.000 description 1
- RQHYCFJBSJKNPT-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]-3-[[3-(trifluoromethoxy)phenyl]methoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OCC=2C=C(OC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)C(F)(F)F)=C1 RQHYCFJBSJKNPT-UHFFFAOYSA-N 0.000 description 1
- XGHLCRJFUPYGJK-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]-3-[[3-(trifluoromethyl)phenyl]methoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OCC=2C=C(C=CC=2)C(F)(F)F)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)C(F)(F)F)=C1 XGHLCRJFUPYGJK-UHFFFAOYSA-N 0.000 description 1
- GNHKFRFIDRMVMU-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]-3-[[3-(trifluoromethyl)phenyl]methoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OCC=2C=C(C=CC=2)C(F)(F)F)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(OC(F)(F)C(F)F)=C1 GNHKFRFIDRMVMU-UHFFFAOYSA-N 0.000 description 1
- YVQCXJRHKSEPKP-UHFFFAOYSA-N 1,1,1-trifluoro-3-[n-[[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]-3-[[3-(trifluoromethylsulfanyl)phenyl]methoxy]anilino]propan-2-ol Chemical compound C=1C=CC(OCC=2C=C(SC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(OC(F)(F)C(F)F)=C1 YVQCXJRHKSEPKP-UHFFFAOYSA-N 0.000 description 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical compound C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 description 1
- NRJAVPSFFCBXDT-HUESYALOSA-N 1,2-distearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCCCC NRJAVPSFFCBXDT-HUESYALOSA-N 0.000 description 1
- LUOZTUYAYLNGTG-UHFFFAOYSA-N 1,3,2-dioxathiepane-4,7-dione Chemical compound O=C1CCC(=O)OSO1 LUOZTUYAYLNGTG-UHFFFAOYSA-N 0.000 description 1
- GDLOOQFSFHLRKT-UHFFFAOYSA-N 1-methylcyclohexane-1-carboxamide Chemical compound NC(=O)C1(C)CCCCC1 GDLOOQFSFHLRKT-UHFFFAOYSA-N 0.000 description 1
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 1
- CWMYWRMDANXCSB-UHFFFAOYSA-N 1-oxoethanesulfonic acid Chemical compound CC(=O)S(O)(=O)=O CWMYWRMDANXCSB-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- DMNKXKHLUXAYPK-UHFFFAOYSA-N 2,2-dimethylpropanamide Chemical compound [CH2]C(C)(C)C(N)=O DMNKXKHLUXAYPK-UHFFFAOYSA-N 0.000 description 1
- ZNNQGSGPVUYWOS-UHFFFAOYSA-N 2-(3-hydroxypropoxy)benzoic acid Chemical compound OCCCOC1=CC=CC=C1C(O)=O ZNNQGSGPVUYWOS-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical class NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- XOCNBMKBDVMRPD-UHFFFAOYSA-N 2-amino-1,1,1-trifluoro-3-[3-[[3-(trifluoromethylsulfanyl)phenyl]methoxy]phenyl]propan-2-ol Chemical compound FC(SC=1C=C(C=CC1)COC=1C=C(C=CC1)CC(C(F)(F)F)(O)N)(F)F XOCNBMKBDVMRPD-UHFFFAOYSA-N 0.000 description 1
- AQZMNAWNLGAUDN-UHFFFAOYSA-N 2-cyclopentyl-4-(4-fluorophenyl)-7,7-dimethyl-3-[4-(trifluoromethyl)benzoyl]-1,4,6,8-tetrahydroquinolin-5-one Chemical compound C1C(C)(C)CC(=O)C(C(C=2C(=O)C=3C=CC(=CC=3)C(F)(F)F)C=3C=CC(F)=CC=3)=C1NC=2C1CCCC1 AQZMNAWNLGAUDN-UHFFFAOYSA-N 0.000 description 1
- HNKQAKJHHVFFRZ-UHFFFAOYSA-N 2-ethoxybenzene-1,3-dicarboxylic acid Chemical compound CCOC1=C(C(O)=O)C=CC=C1C(O)=O HNKQAKJHHVFFRZ-UHFFFAOYSA-N 0.000 description 1
- XCMJQQOMGWGGSI-UHFFFAOYSA-N 2-ethoxypyridine-3-carboxylic acid Chemical compound CCOC1=NC=CC=C1C(O)=O XCMJQQOMGWGGSI-UHFFFAOYSA-N 0.000 description 1
- OEXIDSNKGPWFGB-UHFFFAOYSA-N 2-ethyl-3-(3-hydroxypropyl)benzoic acid Chemical compound CCC1=C(CCCO)C=CC=C1C(O)=O OEXIDSNKGPWFGB-UHFFFAOYSA-N 0.000 description 1
- RESGCFMULOVHHB-UHFFFAOYSA-N 2-ethylpyridine-3-carboxylic acid Chemical compound CCC1=NC=CC=C1C(O)=O RESGCFMULOVHHB-UHFFFAOYSA-N 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 1
- UOBYKYZJUGYBDK-UHFFFAOYSA-N 2-naphthoic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CC=C21 UOBYKYZJUGYBDK-UHFFFAOYSA-N 0.000 description 1
- OXOWWPXTTOCKKU-UHFFFAOYSA-N 2-propoxybenzoic acid Chemical compound CCCOC1=CC=CC=C1C(O)=O OXOWWPXTTOCKKU-UHFFFAOYSA-N 0.000 description 1
- UTIROQMHTFYJCO-UHFFFAOYSA-N 3-[3-(4-chloro-3-ethylphenoxy)-n-(cyclohexylmethyl)anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C1=C(Cl)C(CC)=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC2CCCCC2)=C1 UTIROQMHTFYJCO-UHFFFAOYSA-N 0.000 description 1
- NOWMFAWRDCBIND-UHFFFAOYSA-N 3-[3-(4-chloro-3-ethylphenoxy)-n-(cyclopentylmethyl)anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C1=C(Cl)C(CC)=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC2CCCC2)=C1 NOWMFAWRDCBIND-UHFFFAOYSA-N 0.000 description 1
- CBMFRJWGUSOSID-UHFFFAOYSA-N 3-[3-(4-chloro-3-ethylphenoxy)-n-(cyclopropylmethyl)anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C1=C(Cl)C(CC)=CC(OC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC2CC2)=C1 CBMFRJWGUSOSID-UHFFFAOYSA-N 0.000 description 1
- IELXUOOARVGPDV-UHFFFAOYSA-N 3-[3-(4-chloro-3-ethylphenoxy)propyl-[[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]amino]-1,1,1-trifluoropropan-2-ol Chemical compound C1=C(Cl)C(CC)=CC(OCCCN(CC(O)C(F)(F)F)CC=2C=C(OC(F)(F)C(F)F)C=CC=2)=C1 IELXUOOARVGPDV-UHFFFAOYSA-N 0.000 description 1
- JFMMCLWZKOQZFM-UHFFFAOYSA-N 3-[3-(cyclohexylmethoxy)-n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OCC2CCCCC2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)F)=C1 JFMMCLWZKOQZFM-UHFFFAOYSA-N 0.000 description 1
- DYLDZWMOCOMTDK-UHFFFAOYSA-N 3-[3-(cyclohexylmethoxy)-n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OCC2CCCCC2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)C(F)(F)F)=C1 DYLDZWMOCOMTDK-UHFFFAOYSA-N 0.000 description 1
- AJTZRRKUOPSIAQ-UHFFFAOYSA-N 3-[3-[(3,5-difluorophenyl)methoxy]-n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OCC=2C=C(F)C=C(F)C=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)F)=C1 AJTZRRKUOPSIAQ-UHFFFAOYSA-N 0.000 description 1
- ZLVOSBYUPUTAIL-UHFFFAOYSA-N 3-[3-[(3,5-difluorophenyl)methoxy]-n-[[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OCC=2C=C(F)C=C(F)C=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(OC(F)(F)C(F)F)=C1 ZLVOSBYUPUTAIL-UHFFFAOYSA-N 0.000 description 1
- OMSUQFGKWRCKRO-UHFFFAOYSA-N 3-[3-[(3,5-dimethylphenyl)methoxy]-n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound CC1=CC(C)=CC(COC=2C=C(C=CC=2)N(CC(O)C(F)(F)F)CC=2C(=CC(=CC=2)C(F)(F)F)F)=C1 OMSUQFGKWRCKRO-UHFFFAOYSA-N 0.000 description 1
- KXDULMCJBDQOBL-UHFFFAOYSA-N 3-[3-[3-(difluoromethoxy)phenoxy]-n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C=C(OC(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=C(C(F)(F)F)C=C1F KXDULMCJBDQOBL-UHFFFAOYSA-N 0.000 description 1
- ALRRRXOBRLAYON-UHFFFAOYSA-N 3-[3-[3-(difluoromethoxy)phenoxy]-n-[[3-(1,1,2,2,2-pentafluoroethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C=C(OC(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)F)=C1 ALRRRXOBRLAYON-UHFFFAOYSA-N 0.000 description 1
- HNLAFPBRFDGEGS-UHFFFAOYSA-N 3-[3-[3-(difluoromethoxy)phenoxy]-n-[[3-(1,1,2,2,3,3,3-heptafluoropropyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C=C(OC(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1=CC=CC(C(F)(F)C(F)(F)C(F)(F)F)=C1 HNLAFPBRFDGEGS-UHFFFAOYSA-N 0.000 description 1
- LYJQLTIFINCHOG-UHFFFAOYSA-N 3-[3-[4-chloro-3-(trifluoromethyl)phenoxy]-n-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C=C(C(Cl)=CC=2)C(F)(F)F)=CC=1N(CC(O)C(F)(F)F)CC1=CC=C(C(F)(F)F)C=C1F LYJQLTIFINCHOG-UHFFFAOYSA-N 0.000 description 1
- PDMFGAQMYDKZHO-UHFFFAOYSA-N 3-[[3-(4-chloro-3-ethylphenoxy)-2,2-difluoropropyl]-[[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]amino]-1,1,1-trifluoropropan-2-ol Chemical compound C1=C(Cl)C(CC)=CC(OCC(F)(F)CN(CC(O)C(F)(F)F)CC=2C=C(OC(F)(F)C(F)F)C=CC=2)=C1 PDMFGAQMYDKZHO-UHFFFAOYSA-N 0.000 description 1
- WJYIXIZILOSGLK-UHFFFAOYSA-N 3-[cyclohexyl-[[3-(1,1,2,2-tetrafluoroethoxy)phenyl]methyl]amino]-1,1,1-trifluoropropan-2-ol Chemical compound C1CCCCC1N(CC(O)C(F)(F)F)CC1=CC=CC(OC(F)(F)C(F)F)=C1 WJYIXIZILOSGLK-UHFFFAOYSA-N 0.000 description 1
- NWQRSEYNICPJNU-UHFFFAOYSA-N 3-[n-(cyclohexylmethyl)-3-(2,3-dichlorophenoxy)anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C(=C(Cl)C=CC=2)Cl)=CC=1N(CC(O)C(F)(F)F)CC1CCCCC1 NWQRSEYNICPJNU-UHFFFAOYSA-N 0.000 description 1
- KCKMIAHDABOZCP-UHFFFAOYSA-N 3-[n-(cyclohexylmethyl)-3-[3-(trifluoromethoxy)phenoxy]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C=C(OC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1CCCCC1 KCKMIAHDABOZCP-UHFFFAOYSA-N 0.000 description 1
- PDRRNGOHAFYULU-UHFFFAOYSA-N 3-[n-(cyclopentylmethyl)-3-[3-(trifluoromethoxy)phenoxy]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C=C(OC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1CCCC1 PDRRNGOHAFYULU-UHFFFAOYSA-N 0.000 description 1
- NKHZHGRPOAULFW-UHFFFAOYSA-N 3-[n-(cyclopropylmethyl)-3-(2,3-dichlorophenoxy)anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C(=C(Cl)C=CC=2)Cl)=CC=1N(CC(O)C(F)(F)F)CC1CC1 NKHZHGRPOAULFW-UHFFFAOYSA-N 0.000 description 1
- RJSOPXTYTBYVQK-UHFFFAOYSA-N 3-[n-(cyclopropylmethyl)-3-[3-(trifluoromethoxy)phenoxy]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OC=2C=C(OC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1CC1 RJSOPXTYTBYVQK-UHFFFAOYSA-N 0.000 description 1
- CXQLLCRBPAXZQY-UHFFFAOYSA-N 3-[n-(cyclopropylmethyl)-3-[[3-(trifluoromethoxy)phenyl]methoxy]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OCC=2C=C(OC(F)(F)F)C=CC=2)=CC=1N(CC(O)C(F)(F)F)CC1CC1 CXQLLCRBPAXZQY-UHFFFAOYSA-N 0.000 description 1
- DTTITCFMNCCGNB-UHFFFAOYSA-N 3-[n-(cyclopropylmethyl)-3-[[3-(trifluoromethyl)phenyl]methoxy]anilino]-1,1,1-trifluoropropan-2-ol Chemical compound C=1C=CC(OCC=2C=C(C=CC=2)C(F)(F)F)=CC=1N(CC(O)C(F)(F)F)CC1CC1 DTTITCFMNCCGNB-UHFFFAOYSA-N 0.000 description 1
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 1
- CXMYSDLCKRTJIM-UHFFFAOYSA-N 3-dodecyl-4-(3-methoxyphenyl)-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCC1=NNC(=S)N1C1=CC=CC(OC)=C1 CXMYSDLCKRTJIM-UHFFFAOYSA-N 0.000 description 1
- ZDVQETDUMMFBEO-UHFFFAOYSA-N 3-ethoxyphthalic acid Chemical compound CCOC1=CC=CC(C(O)=O)=C1C(O)=O ZDVQETDUMMFBEO-UHFFFAOYSA-N 0.000 description 1
- QTVCNUYGSSNMDT-UHFFFAOYSA-N 3-ethoxypyridine-2-carboxylic acid Chemical compound CCOC1=CC=CN=C1C(O)=O QTVCNUYGSSNMDT-UHFFFAOYSA-N 0.000 description 1
- NMGBFVPQUCLJGM-UHFFFAOYSA-N 3-ethylphthalic acid Chemical compound CCC1=CC=CC(C(O)=O)=C1C(O)=O NMGBFVPQUCLJGM-UHFFFAOYSA-N 0.000 description 1
- INTNEELQXPKMNM-UHFFFAOYSA-N 3-ethylpyridine-2-carboxylic acid Chemical compound CCC1=CC=CN=C1C(O)=O INTNEELQXPKMNM-UHFFFAOYSA-N 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000006495 3-trifluoromethyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1[H])C([H])([H])*)C(F)(F)F 0.000 description 1
- VBYFZWIHXIZTAD-UHFFFAOYSA-N 4-(2,5-dimethoxyphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC(OC)=CC=C1OC VBYFZWIHXIZTAD-UHFFFAOYSA-N 0.000 description 1
- KARZWFFLADFSJJ-UHFFFAOYSA-N 4-(2,6-dimethylphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=C(C)C=CC=C1C KARZWFFLADFSJJ-UHFFFAOYSA-N 0.000 description 1
- UVFPUNZVHJMCQM-UHFFFAOYSA-N 4-(2-chlorophenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC=CC=C1Cl UVFPUNZVHJMCQM-UHFFFAOYSA-N 0.000 description 1
- QXDZQZLKZFBCMW-UHFFFAOYSA-N 4-(2-methylsulfanylphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC=CC=C1SC QXDZQZLKZFBCMW-UHFFFAOYSA-N 0.000 description 1
- NSWWHSXVKSHJOE-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC=C(OC)C(OC)=C1 NSWWHSXVKSHJOE-UHFFFAOYSA-N 0.000 description 1
- UNQVXTZCFDXMRU-UHFFFAOYSA-N 4-(3-chloro-4-methylphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC=C(C)C(Cl)=C1 UNQVXTZCFDXMRU-UHFFFAOYSA-N 0.000 description 1
- RDJMWIPWPLTLLP-UHFFFAOYSA-N 4-(3-fluorophenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC=CC(F)=C1 RDJMWIPWPLTLLP-UHFFFAOYSA-N 0.000 description 1
- ARYGZDOADGGOPU-UHFFFAOYSA-N 4-(3-methoxyphenyl)-3-undecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCC1=NNC(=S)N1C1=CC=CC(OC)=C1 ARYGZDOADGGOPU-UHFFFAOYSA-N 0.000 description 1
- ZECLWJRIUPEVJU-UHFFFAOYSA-N 4-(4-methoxyphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC=C(OC)C=C1 ZECLWJRIUPEVJU-UHFFFAOYSA-N 0.000 description 1
- UUHUXSPURVSFIS-UHFFFAOYSA-N 4-(4-phenoxyphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C(C=C1)=CC=C1OC1=CC=CC=C1 UUHUXSPURVSFIS-UHFFFAOYSA-N 0.000 description 1
- PNNZCTKYKGKWTI-UHFFFAOYSA-N 4-(4-phenylmethoxyphenyl)-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C(C=C1)=CC=C1OCC1=CC=CC=C1 PNNZCTKYKGKWTI-UHFFFAOYSA-N 0.000 description 1
- MEUAVGJWGDPTLF-UHFFFAOYSA-N 4-(5-benzenesulfonylamino-1-methyl-1h-benzoimidazol-2-ylmethyl)-benzamidine Chemical compound N=1C2=CC(NS(=O)(=O)C=3C=CC=CC=3)=CC=C2N(C)C=1CC1=CC=C(C(N)=N)C=C1 MEUAVGJWGDPTLF-UHFFFAOYSA-N 0.000 description 1
- ABIPELMUCZBLQH-UHFFFAOYSA-N 4-[(2,6-dichloropyridin-4-yl)methyl-methoxycarbonylamino]-6,7-dimethoxy-2-methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid Chemical compound C1C(C)N(C(O)=O)C2=CC(OC)=C(OC)C=C2C1N(C(=O)OC)CC1=CC(Cl)=NC(Cl)=C1 ABIPELMUCZBLQH-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- 125000002528 4-isopropyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- YUEVNAMKBJHWDG-UHFFFAOYSA-N 4-phenyl-1,2,3,4-tetrahydroquinoline Chemical class C12=CC=CC=C2NCCC1C1=CC=CC=C1 YUEVNAMKBJHWDG-UHFFFAOYSA-N 0.000 description 1
- DAKIEYCXFYULBC-UHFFFAOYSA-N 4-pyridin-3-yl-3-tridecyl-1h-1,2,4-triazole-5-thione Chemical compound CCCCCCCCCCCCCC1=NNC(=S)N1C1=CC=CN=C1 DAKIEYCXFYULBC-UHFFFAOYSA-N 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
- RLOFKIKCAWCLRP-UHFFFAOYSA-N 5-[[5-carboxy-6-(difluoromethyl)-4-(2-methylpropyl)-2-(trifluoromethyl)pyridin-3-yl]disulfanyl]-2-(difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxylic acid Chemical compound FC(F)(F)C1=NC(C(F)F)=C(C(O)=O)C(CC(C)C)=C1SSC1=C(CC(C)C)C(C(O)=O)=C(C(F)F)N=C1C(F)(F)F RLOFKIKCAWCLRP-UHFFFAOYSA-N 0.000 description 1
- 125000004008 6 membered carbocyclic group Chemical group 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- VVNLIZOGBDPODZ-UHFFFAOYSA-N 6h-quinolin-2-one Chemical class C1C=CC2=NC(=O)C=CC2=C1 VVNLIZOGBDPODZ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 101100515517 Arabidopsis thaliana XI-I gene Proteins 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- ZLGMVGKKFOADIY-UHFFFAOYSA-N C=1(C=CC=C2C1C=CC=CC2)C(=O)N Chemical compound C=1(C=CC=C2C1C=CC=CC2)C(=O)N ZLGMVGKKFOADIY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 101150064053 Rffl gene Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- UYWNJNXEHSUWLE-HFWGUVFESA-N [(2R)-3-hexadecanoyloxy-2-[(Z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC UYWNJNXEHSUWLE-HFWGUVFESA-N 0.000 description 1
- UTXCDRWZMZADNL-UHFFFAOYSA-N [2-cyclopentyl-4-(4-fluorophenyl)-5-hydroxy-7,7-dimethyl-6,8-dihydro-5h-quinolin-3-yl]-[4-(trifluoromethyl)phenyl]methanone Chemical compound C1C(C)(C)CC(O)C(C(=C2C(=O)C=3C=CC(=CC=3)C(F)(F)F)C=3C=CC(F)=CC=3)=C1N=C2C1CCCC1 UTXCDRWZMZADNL-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- ZNPLZHBZUSCANM-UHFFFAOYSA-N acetic acid;benzene-1,3-dicarboxylic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC(C(O)=O)=C1 ZNPLZHBZUSCANM-UHFFFAOYSA-N 0.000 description 1
- PLEULVPCZZDBNB-UHFFFAOYSA-N acetic acid;butanedioic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)CCC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O PLEULVPCZZDBNB-UHFFFAOYSA-N 0.000 description 1
- FMTQGBMMIVVKSN-UHFFFAOYSA-N acetic acid;terephthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=C(C(O)=O)C=C1 FMTQGBMMIVVKSN-UHFFFAOYSA-N 0.000 description 1
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000006323 alkenyl amino group Chemical group 0.000 description 1
- 125000005082 alkoxyalkenyl group Chemical group 0.000 description 1
- 125000005085 alkoxycarbonylalkoxy group Chemical group 0.000 description 1
- 125000004947 alkyl aryl amino group Chemical group 0.000 description 1
- 125000005197 alkyl carbonyloxy alkyl group Chemical group 0.000 description 1
- 125000005011 alkyl ether group Chemical group 0.000 description 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 1
- 125000006319 alkynyl amino group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000005021 aminoalkenyl group Chemical group 0.000 description 1
- 125000005014 aminoalkynyl group Chemical group 0.000 description 1
- 125000005001 aminoaryl group Chemical group 0.000 description 1
- 125000005097 aminocarbonylalkyl group Chemical group 0.000 description 1
- 125000005214 aminoheteroaryl group Chemical group 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 125000005333 aroyloxy group Chemical group 0.000 description 1
- 125000004659 aryl alkyl thio group Chemical group 0.000 description 1
- 125000005129 aryl carbonyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012911 assay medium Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 150000004074 biphenyls Chemical class 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- VHEMBTYWURNBQQ-UHFFFAOYSA-N butanoic acid;phthalic acid Chemical compound CCCC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O VHEMBTYWURNBQQ-UHFFFAOYSA-N 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229940078495 calcium phosphate dibasic Drugs 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 125000005626 carbonium group Chemical group 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- 125000005159 cyanoalkoxy group Chemical group 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 1
- 125000005366 cycloalkylthio group Chemical group 0.000 description 1
- DSLSPCZKJILYBT-UHFFFAOYSA-N cyclopentene-1-carboxamide Chemical compound NC(=O)C1=CCCC1 DSLSPCZKJILYBT-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 125000004986 diarylamino group Chemical group 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 125000005240 diheteroarylamino group Chemical group 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- HVFFICXFJBAZMU-UHFFFAOYSA-N ethoxy dihydrogen phosphate Chemical compound CCOOP(O)(O)=O HVFFICXFJBAZMU-UHFFFAOYSA-N 0.000 description 1
- QCLAORQMXJANRH-KUHUBIRLSA-N ethyl (2r,4s)-4-[(3,5-dinitrophenyl)methyl-methoxycarbonylamino]-6,7-dimethoxy-2-methyl-3,4-dihydro-2h-quinoline-1-carboxylate Chemical compound COC(=O)N([C@H]1C[C@@H](C)N(C2=CC(OC)=C(OC)C=C21)C(=O)OCC)CC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 QCLAORQMXJANRH-KUHUBIRLSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 125000004475 heteroaralkyl group Chemical group 0.000 description 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 1
- 125000006517 heterocyclyl carbonyl group Chemical group 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 description 1
- 229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
- 230000000871 hypocholesterolemic effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- LVPMIMZXDYBCDF-UHFFFAOYSA-N isocinchomeronic acid Chemical class OC(=O)C1=CC=C(C(O)=O)N=C1 LVPMIMZXDYBCDF-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-L isophthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC(C([O-])=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-L 0.000 description 1
- 238000010902 jet-milling Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000012768 molten material Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- ZQTWLAFVLXDPPX-UHFFFAOYSA-N n-[3-(4-tert-butylphenyl)-1-(3-chlorophenyl)-1-hydroxypropan-2-yl]-5-chloronaphthalene-1-carboxamide Chemical compound C1=CC(C(C)(C)C)=CC=C1CC(C(O)C=1C=C(Cl)C=CC=1)NC(=O)C1=CC=CC2=C(Cl)C=CC=C12 ZQTWLAFVLXDPPX-UHFFFAOYSA-N 0.000 description 1
- RMHJJUOPOWPRBP-UHFFFAOYSA-N naphthalene-1-carboxamide Chemical compound C1=CC=C2C(C(=O)N)=CC=CC2=C1 RMHJJUOPOWPRBP-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940081066 picolinic acid Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- GJAWHXHKYYXBSV-UHFFFAOYSA-N pyridinedicarboxylic acid Natural products OC(=O)C1=CC=CN=C1C(O)=O GJAWHXHKYYXBSV-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- RAYMXZBXQCGRGX-UHFFFAOYSA-N quinoline-5-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=N1 RAYMXZBXQCGRGX-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940071117 starch glycolate Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000006211 transdermal dosage form Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- 125000005106 triarylsilyl group Chemical group 0.000 description 1
- 125000000169 tricyclic heterocycle group Chemical group 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- FKVMWDZRDMCIAJ-UHFFFAOYSA-N undecanamide Chemical compound CCCCCCCCCCC(N)=O FKVMWDZRDMCIAJ-UHFFFAOYSA-N 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc oxide Inorganic materials [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43532802P | 2002-12-20 | 2002-12-20 | |
| PCT/IB2003/006170 WO2004056395A1 (en) | 2002-12-20 | 2003-12-18 | Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05006167A true MXPA05006167A (es) | 2005-08-26 |
Family
ID=32682218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05006167A MXPA05006167A (es) | 2002-12-20 | 2003-12-18 | Composiciones de inhibidores de la proteina de transferencia de colesteril ester e inhibidores de la hmg-coa reductasa. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040132771A1 (enExample) |
| EP (1) | EP1578448A1 (enExample) |
| JP (1) | JP2006512361A (enExample) |
| AU (2) | AU2003285703A1 (enExample) |
| BR (1) | BR0317520A (enExample) |
| CA (1) | CA2510458A1 (enExample) |
| MX (1) | MXPA05006167A (enExample) |
| WO (2) | WO2004056395A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EE200400024A (et) * | 2001-06-21 | 2004-06-15 | Pfizer Products Inc. | Kolesterüülestri ülekandevalgu inhibiitorite iseemulgeeruvad formulatsioonid |
| KR20050088190A (ko) * | 2002-12-20 | 2005-09-02 | 화이자 프로덕츠 인코포레이티드 | 콜레스테릴 에스터 전달 단백질 억제제 및 hmg-coa환원 효소 억제제를 포함하는 투약 형태 |
| BRPI0410840A (pt) | 2003-05-30 | 2006-07-04 | Ranbaxy Lab Ltd | derivados substituìdos de pirrol, composição farmacêutica contendo os mesmos e processo para sua preparação |
| JP2008521878A (ja) * | 2004-12-02 | 2008-06-26 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 非晶質アトルバスタチンの医薬組成物及びその製造のための方法 |
| CA2601762A1 (en) * | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors |
| WO2006085217A2 (en) * | 2005-02-08 | 2006-08-17 | Pfizer Products Inc. | Solid adsorbates of hydrophobic drugs |
| EP1893178A1 (en) * | 2005-05-31 | 2008-03-05 | Pfizer Products Incorporated | PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS |
| JP2009514851A (ja) * | 2005-11-08 | 2009-04-09 | ランバクシー ラボラトリーズ リミテッド | (3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法 |
| AR059838A1 (es) * | 2006-03-14 | 2008-04-30 | Ranbaxy Lab Ltd | Formulaciones para dosis estabilizantes de estatina |
| WO2007134158A2 (en) * | 2006-05-12 | 2007-11-22 | Drugtech Corporation | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy |
| US8099298B2 (en) * | 2007-02-14 | 2012-01-17 | Genelex, Inc | Genetic data analysis and database tools |
| CA2716671A1 (en) * | 2008-02-27 | 2009-09-03 | Thommen Medical Ag | Implant and method for the manufacture thereof |
| AU2009224418B2 (en) | 2008-03-11 | 2014-12-11 | Aska Pharmaceutical Co., Ltd. | Solid dispersion, pharmaceutical compositions containing the same, and processes for the production of both |
| JP2011525901A (ja) * | 2008-06-27 | 2011-09-29 | アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ | ロスバスタチンカルシウム含有医薬組成物 |
| WO2010092925A1 (ja) * | 2009-02-12 | 2010-08-19 | あすか製薬株式会社 | 固体分散体とその医薬組成物、並びにそれらの製造方法 |
| US8877221B2 (en) | 2010-10-27 | 2014-11-04 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same |
| US9107983B2 (en) | 2010-10-27 | 2015-08-18 | Warsaw Orthopedic, Inc. | Osteoconductive matrices comprising statins |
| WO2012170417A2 (en) | 2011-06-06 | 2012-12-13 | Warsaw Orthopedic, Inc. | Methods and compositions to enhance bone growth comprising a statin |
| WO2014121133A2 (en) | 2013-02-03 | 2014-08-07 | Genelex Corporation | Systems and methods for quantification and presentation of medical risk arising from unknown factors |
| US20200147032A1 (en) | 2018-11-14 | 2020-05-14 | Robert K. Prud'homme | Dihydromyricetin hot melt extrusion formulations and methods for forming them |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US35125A (en) * | 1862-04-29 | Improvement in spring-balances | ||
| JPS5612114B2 (enExample) * | 1974-06-07 | 1981-03-18 | ||
| US4294926A (en) * | 1979-06-15 | 1981-10-13 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4231938A (en) * | 1979-06-15 | 1980-11-04 | Merck & Co., Inc. | Hypocholesteremic fermentation products and process of preparation |
| US4319039A (en) * | 1979-06-15 | 1982-03-09 | Merck & Co., Inc. | Preparation of ammonium salt of hypocholesteremic fermentation product |
| US4444784A (en) * | 1980-08-05 | 1984-04-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| DK149080C (da) * | 1980-06-06 | 1986-07-28 | Sankyo Co | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
| US4450171A (en) * | 1980-08-05 | 1984-05-22 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| JPS5889191A (ja) * | 1981-11-20 | 1983-05-27 | Sankyo Co Ltd | 3−ヒドロキシ−ml−236b誘導体の製造法 |
| FR2525108B1 (fr) * | 1982-04-19 | 1989-05-12 | Elan Corp Ltd | Medicaments a haut degre de solubilite et procede pour leur obtention |
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| US5354772A (en) * | 1982-11-22 | 1994-10-11 | Sandoz Pharm. Corp. | Indole analogs of mevalonolactone and derivatives thereof |
| US4911165A (en) * | 1983-01-12 | 1990-03-27 | Ethicon, Inc. | Pliabilized polypropylene surgical filaments |
| US4686237A (en) * | 1984-07-24 | 1987-08-11 | Sandoz Pharmaceuticals Corp. | Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof |
| US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
| US5225192A (en) * | 1988-10-17 | 1993-07-06 | Vectorpharma International S.P.A. | Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate |
| US5569469A (en) * | 1984-10-16 | 1996-10-29 | Vectorpharma International, S.P.A. | Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate |
| IE63321B1 (en) * | 1986-02-03 | 1995-04-05 | Elan Corp Plc | Drug delivery system |
| US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
| US5110940A (en) * | 1987-02-25 | 1992-05-05 | Bristol-Myers Company | Antihypercholesterolemic tetrazole compounds |
| US4820850A (en) * | 1987-07-10 | 1989-04-11 | Merck & Co., Inc. | Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof |
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| US5180589A (en) * | 1988-03-31 | 1993-01-19 | E. R. Squibb & Sons, Inc. | Pravastatin pharmaceuatical compositions having good stability |
| IT1216570B (it) * | 1988-04-08 | 1990-03-08 | Vectorpharma Int | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. |
| US5049696A (en) * | 1988-04-11 | 1991-09-17 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US4916239A (en) * | 1988-07-19 | 1990-04-10 | Merck & Co., Inc. | Process for the lactonization of mevinic acids and analogs thereof |
| US4866058A (en) * | 1988-07-27 | 1989-09-12 | Izydore Robert A | Method for control of hyperlipidemia |
| IT1226726B (it) * | 1988-07-29 | 1991-02-05 | Zambon Spa | Composti attivi come inibitori della biosintesi del colesterolo. |
| US5196440A (en) * | 1988-07-29 | 1993-03-23 | Zambon Group S.P.A. | Compounds active as inhibitors of the cholesterol biosynthesis |
| US5011947A (en) * | 1988-08-25 | 1991-04-30 | Bristol-Myers | Antihypercholesterolemic alkylene compounds |
| US5290946A (en) * | 1988-10-13 | 1994-03-01 | Sandoz Ltd. | Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes |
| US5118853A (en) * | 1988-10-13 | 1992-06-02 | Sandoz Ltd. | Processes for the synthesis of 3-disubstituted aminoacroleins |
| IT1227626B (it) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
| US5099035A (en) * | 1989-02-27 | 1992-03-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| US5166364A (en) * | 1989-02-27 | 1992-11-24 | E. R. Squibb & Sons, Inc. | Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| US5189164A (en) * | 1989-05-22 | 1993-02-23 | Sandoz Ltd. | Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof |
| US5010105A (en) * | 1989-06-09 | 1991-04-23 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US4949437A (en) * | 1989-07-11 | 1990-08-21 | Anderson Travis B | Shoelace knot retaining apparatus |
| FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| US4970221A (en) * | 1989-07-28 | 1990-11-13 | E. R. Squibb & Sons, Inc. | 3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| US5106992A (en) * | 1989-07-28 | 1992-04-21 | E. R. Squibb & Sons, Inc. | 3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same |
| US5189180A (en) * | 1989-09-28 | 1993-02-23 | E. R. Squibb & Sons, Inc. | Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
| US5025017A (en) * | 1989-09-28 | 1991-06-18 | E. R. Squibb & Sons, Inc. | Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates |
| US5217992A (en) * | 1989-10-04 | 1993-06-08 | Bristol-Myers Squibb Company | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders |
| IT1237793B (it) * | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
| US5049577A (en) * | 1990-01-29 | 1991-09-17 | E. R. Squibb & Sons, Inc. | 2-pyrrolidone substituted dihydroxy alkanoic, alkenoic and alkynoic acids, compositions and HMG-CoA reductase inhibition therewith |
| IT1241417B (it) * | 1990-03-06 | 1994-01-14 | Vectorpharma Int | Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione |
| US5177080A (en) * | 1990-12-14 | 1993-01-05 | Bayer Aktiengesellschaft | Substituted pyridyl-dihydroxy-heptenoic acid and its salts |
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| HU9203780D0 (en) * | 1991-12-12 | 1993-03-29 | Sandoz Ag | Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them |
| US5157134A (en) * | 1992-03-12 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Dihydroxyheptanoic acids containing an oxabicycloheptane nucleus useful as antihypercholesterolemic agents |
| US5298627A (en) * | 1993-03-03 | 1994-03-29 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| US5773021A (en) * | 1994-03-14 | 1998-06-30 | Vetoquinol S.A. | Bioadhesive ophthalmic insert |
| TW487582B (en) * | 1995-08-11 | 2002-05-21 | Nissan Chemical Ind Ltd | Method for converting sparingly water-soluble medical substance to amorphous state |
| HRP970330B1 (en) * | 1996-07-08 | 2004-06-30 | Bayer Ag | Cycloalkano pyridines |
| DE19627431A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | Heterocyclisch kondensierte Pyridine |
| US6207671B1 (en) * | 1996-07-08 | 2001-03-27 | Bayer Aktiengesellschaft | Cycloalkano-pyridines |
| JPH11131049A (ja) * | 1997-10-28 | 1999-05-18 | Japan Science & Technology Corp | シリカ有機物複合体とその製造方法 |
| US6197786B1 (en) * | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| US6147089A (en) * | 1998-09-17 | 2000-11-14 | Pfizer Inc. | Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines |
| GT199900147A (es) * | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. | |
| US6140342A (en) * | 1998-09-17 | 2000-10-31 | Pfizer Inc. | Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
| US6147090A (en) * | 1998-09-17 | 2000-11-14 | Pfizer Inc. | 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines |
| WO2000038722A1 (en) * | 1998-12-23 | 2000-07-06 | G.D. Searle & Co. | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS |
| EP1027885B1 (en) * | 1999-02-09 | 2008-07-09 | Pfizer Products Inc. | Basic drug compositions with enhanced bioavailability |
| HN2000000203A (es) * | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
| CO5271716A1 (es) * | 1999-11-30 | 2003-04-30 | Pfizer Prod Inc | Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida |
| US7115279B2 (en) * | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| CA2419406A1 (en) * | 2000-08-15 | 2002-02-21 | Pfizer Products Inc. | Pharmaceutical combinations of torcetrapib and atorvastatin or hydroxy derivatives for the treatment of atherosclerosis, angina and low hdl levels |
| NZ529490A (en) * | 2001-06-22 | 2005-08-26 | Pfizer Prod Inc | Pharmaceutical compositions of adsorbates of amorphous drug |
| US20030099708A1 (en) * | 2001-10-29 | 2003-05-29 | Therics, Inc | Printing or dispensing a suspension such as three-dimensional printing of dosage forms |
| AU2003260239A1 (en) * | 2002-06-26 | 2004-01-19 | Tuo Jin | Solid dosage forms for rapid dissolution of poorly soluble drugs |
| US20040053842A1 (en) * | 2002-07-02 | 2004-03-18 | Pfizer Inc. | Methods of treatment with CETP inhibitors and antihypertensive agents |
-
2003
- 2003-10-06 US US10/678,145 patent/US20040132771A1/en not_active Abandoned
- 2003-12-18 JP JP2004561920A patent/JP2006512361A/ja active Pending
- 2003-12-18 CA CA002510458A patent/CA2510458A1/en not_active Abandoned
- 2003-12-18 EP EP03778668A patent/EP1578448A1/en not_active Withdrawn
- 2003-12-18 WO PCT/IB2003/006170 patent/WO2004056395A1/en not_active Ceased
- 2003-12-18 MX MXPA05006167A patent/MXPA05006167A/es not_active Application Discontinuation
- 2003-12-18 AU AU2003285703A patent/AU2003285703A1/en not_active Abandoned
- 2003-12-18 BR BR0317520-0A patent/BR0317520A/pt not_active IP Right Cessation
- 2003-12-18 WO PCT/IB2003/006240 patent/WO2004056396A1/en not_active Ceased
- 2003-12-18 AU AU2003285677A patent/AU2003285677A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BR0317520A (pt) | 2005-11-16 |
| JP2006512361A (ja) | 2006-04-13 |
| CA2510458A1 (en) | 2004-07-08 |
| AU2003285703A1 (en) | 2004-07-14 |
| US20040132771A1 (en) | 2004-07-08 |
| EP1578448A1 (en) | 2005-09-28 |
| WO2004056395A1 (en) | 2004-07-08 |
| AU2003285677A1 (en) | 2004-07-14 |
| WO2004056396A1 (en) | 2004-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1581210B1 (en) | Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor | |
| EP1961419B1 (en) | Dosage forms comprising a CETP inhibitor and an HMG-CoA reductase inhibitor | |
| KR20060033033A (ko) | 콜레스테릴 에스테르 전달 단백질 억제제의 제어 방출 및hmg-coa 리덕타제 억제제의 순간 방출을 제공하는제형 | |
| MXPA05006167A (es) | Composiciones de inhibidores de la proteina de transferencia de colesteril ester e inhibidores de la hmg-coa reductasa. | |
| CA2473991C (en) | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor | |
| CA2474447A1 (en) | Pharmaceutical compositions comprising a solid amorphous dispersion of cholesteryl ester transfer protein inhibitors | |
| US8828438B2 (en) | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase | |
| MXPA05006566A (es) | Formas de dosificacion que comprenden un inhibidor de la proteina de transferencia de esteres de colesterilo y un inhibidor de la 3-hidroxi-3-metilglutaril-coenzima a-reductasa. | |
| AU2003201713A1 (en) | Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |